Bryan Ball serves as our Chief Quality Officer. Prior to joining Intercept, Mr. Ball was Chief Quality Officer of Immunomedics, Inc., where he was responsible for all aspects of Quality for product development, clinical trials, manufacturing, testing and distribution of the company’s clinical stage candidates and first commercial product. Mr. Ball has served in management positions at several companies, including as Senior Vice President, Quality, Environmental Health and Safety at Mallinckrodt Pharmaceuticals and Vice President positions in the Quality departments of Ikaria, Inc. and Boehringer Ingelheim. Mr. Ball holds an M.B.A from Westminster College, a M.Sc. in cell biology from University of North Carolina, Charlotte, and a B.Sc. in biology from Central Michigan University.
Jared M. Freedberg serves as our General Counsel. Mr. Freedberg was previously General Counsel and Secretary of Immunomedics, Inc. Prior to joining Immunomedics, Mr. Freedberg served as General Counsel, Specialty Generics Operating Division, and Vice President, Legal, Business Development and Licensing at Mallinckrodt Pharmaceuticals. From 2001 through 2016, he held positions of increasing responsibility at Covance Inc. and was a member of Covance's Global Executive Leadership Team as Head of Strategy and Business Development from 2014 to 2016. Mr. Freedberg received a Juris Doctor from Duke University School of Law and a bachelor’s degree from the University of Pennsylvania.